Iovance Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin).
IOVA Key Statistics
Stock Snapshot
With a market cap of 3.64B, Iovance Biotherapeutics(IOVA) trades at $8.05. The stock has a price-to-earnings ratio of -15.48.
On 2026-11-08, Iovance Biotherapeutics(IOVA) stock moved within a range of $7.72 to $8.28. With shares now at $8.05, the stock is trading +4.2% above its intraday low and -2.8% below the session's peak.
Trading volume for Iovance Biotherapeutics(IOVA) stock has reached 12.96M, versus its average volume of 20.59M.
The stock's 52-week range extends from a low of $2.08 to a high of $15.37.
The stock's 52-week range extends from a low of $2.08 to a high of $15.37.
IOVA News
...
Iovance Biotherapeutics, Inc. (IOVA Quick QuoteIOVA - Free Report) emphasized accelerating Amtagvi adoption, improving profitability metrics and advancing...
Iovance Biotherapeutics (IOVA) has reported third quarter 2026 results, posting revenue of US$121.47 million and a net loss of US$22.27 million, or a basic and...
Analyst ratings
80%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.